Stecker G, Fournet B, HondiAssah T, Spik G, Montreuil J, Maroteaux P, Durand P, Farriaux J P
C R Acad Hebd Seances Acad Sci D. 1976 Feb 16;282(7):671-3.
The urine of five patients with three distinct diseases ("I Cell disease" and two new types of mucolipidosis) contains sialic acid-rich oligosaccharides in a high amount: 50 to 500 fold the normal. The structure of the major components are as follows alpha-NANA-(2 leads to 6)-beta-Gal-(1 leads to 4)-beta-GlcNAc-(1 leads to 2)-alpha-Man-(1 leads to 3)-beta-Man-(1 leads to 4)-GlcNAc, [alpha-NANA-(2 leads to 6) beta-Gal-(1 leads to 4)-beta-Glc-NAc-(1 leads to 2)-alpha-Man-(1 leads to 3) [beta-Gal-(1 leads to 4)-beta-GlcNAc-(1 leads to 2)-alpha-Man-(1 leads to 6)]-beta-Man-(1 leads to 4)-GlcNAc and alpha-NANA-(2 leads to 6)-beta-Gal-(1 leads to 4)-beta-GlcNAc-(1 leads to 2)-alpha-Man-(1 leads to 3)[alpha-NANA-(2 leads to 6)-beta-Gal-(1 leads to 4)-beta-GlcNAc-(1 leads to 2)-alpha-Man-(1 leads to 6)[-beta-Man-(1 leads to 4)-GlcNAC. These results suggest that a dieficit in alpha-neuraminidase is associated to these three different disorders and that an endo-beta-D-N-acetyglucosaminidase is able to release sialyloligosaccharides by splitting the sialyglycans of glycoproteins.
五名患有三种不同疾病(“I型细胞病”和两种新型黏脂贮积症)的患者尿液中含有大量富含唾液酸的寡糖:是正常量的50至500倍。主要成分的结构如下:α-N-乙酰神经氨酸-(2→6)-β-半乳糖-(1→4)-β-氨基葡萄糖-(1→2)-α-甘露糖-(1→3)-β-甘露糖-(1→4)-氨基葡萄糖,[α-N-乙酰神经氨酸-(2→6)β-半乳糖-(1→4)-β-葡萄糖胺-(1→2)-α-甘露糖-(1→3)[β-半乳糖-(1→4)-β-氨基葡萄糖-(1→2)-α-甘露糖-(1→6)]-β-甘露糖-(1→4)-氨基葡萄糖和α-N-乙酰神经氨酸-(2→6)-β-半乳糖-(1→4)-β-氨基葡萄糖-(1→2)-α-甘露糖-(1→3)[α-N-乙酰神经氨酸-(2→6)-β-半乳糖-(1→4)-β-氨基葡萄糖-(1→2)-α-甘露糖-(1→6)[-β-甘露糖-(1→4)-氨基葡萄糖。这些结果表明,α-神经氨酸酶缺乏与这三种不同疾病有关,并且一种内切β-D-N-乙酰葡糖胺酶能够通过裂解糖蛋白的唾液酸聚糖来释放唾液酸寡糖。